Mitomycin C modulates DNA-double strand break repair genes in cervical carcinoma cells

Yun Hee Kang1, Kyung-Ae Lee, Jung-Hee Kim

  • 1Laboratory of Cell and Immuno-biochemistry, Department of Bioscience and Biotechnology, Bio/Molecular Informatics Center, Konkuk University, Hwayang-dong 1, Gwangjin-gu, Seoul, 143-701, South Korea.

Amino Acids
|March 31, 2010
PubMed

Insights

Mitomycin C alters protein expression in cervical cancer cells, down-regulating DNA repair molecules and suppressing cell growth. This study identifies specific protein modulators involved in the anti-cancer effects of mitomycin C.

Area of Science:

  • Oncology
  • Molecular Biology
  • Proteomics

Background:

  • Cervical carcinoma is a significant global health concern.
  • Mitomycin C is a chemotherapeutic agent used in cancer treatment.
  • Previous studies elucidated the apoptotic mechanism of mitomycin C in cervical cancer cells via the Fas/FasL pathway.

Purpose of the Study:

  • To identify mitomycin C-induced protein modulators in cervical carcinoma cells.
  • To investigate the impact of mitomycin C on protein expression profiles.
  • To elucidate the molecular mechanisms underlying mitomycin C's anti-cancer effects.

Main Methods:

  • Two-dimensional gel electrophoresis (2-D) and MALDI-TOF mass spectrometry were employed.
  • Protein spots differentially expressed by mitomycin C treatment were selected and identified.
  • Gene expression analysis of KUB3, Brca1, and E6 was performed in HPV-positive cervical cancer cells.

Main Results:

  • Twenty protein spots were identified, with 11 down-regulated and 9 up-regulated by mitomycin C.
  • Specific proteins like Ku70-binding protein (KUB3), MHC class I antigen, and others were suppressed.
  • Proteins such as heat shock 60 kDa protein 1, NADP-dependent malic enzyme, and cyclin B2 were induced.
  • Mitomycin C down-regulated KUB3, Brca1, and E6 gene expression in SiHa and SiHa/pRSV-luc cells.

Conclusions:

  • Mitomycin C treatment leads to significant alterations in protein expression in cervical cancer cells.
  • The drug down-regulates key proteins involved in the DNA double-strand break repair system (non-homologous end joining and homologous recombination).
  • These modulations in DNA repair pathways contribute to the suppression of cervical cancer cell growth by mitomycin C.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...